医学
针灸科
中止
乳腺癌
芳香化酶抑制剂
随机对照试验
物理疗法
内科学
不利影响
临床试验
电针
芳香化酶
癌症
替代医学
病理
作者
Dawn L. Hershman,Joseph M. Unger,Heather Greenlee,Jillian L. Capodice,Danika L. Lew,Amy K. Darke,Alice T. Kengla,Marianne K. Melnik,Carla Walker Jorgensen,William Kreisle,Lori M. Minasian,Michael Fisch,N. Lynn Henry,Katherine D. Crew
出处
期刊:JAMA
[American Medical Association]
日期:2018-07-10
卷期号:320 (2): 167-167
被引量:224
标识
DOI:10.1001/jama.2018.8907
摘要
Importance
Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors and often result in therapy discontinuation. Small studies suggest that acupuncture may decrease aromatase inhibitor–related joint symptoms. Objective
To determine the effect of acupuncture in reducing aromatase inhibitor–related joint pain. Design, Setting, and Patients
Randomized clinical trial conducted at 11 academic centers and clinical sites in the United States from March 2012 to February 2017 (final date of follow-up, September 5, 2017). Eligible patients were postmenopausal women with early-stage breast cancer who were taking an aromatase inhibitor and scored at least 3 on the Brief Pain Inventory Worst Pain (BPI-WP) item (score range, 0-10; higher scores indicate greater pain). Interventions
Patients were randomized 2:1:1 to the true acupuncture (n = 110), sham acupuncture (n = 59), or waitlist control (n = 57) group. True acupuncture and sham acupuncture protocols consisted of 12 acupuncture sessions over 6 weeks (2 sessions per week), followed by 1 session per week for 6 weeks. The waitlist control group did not receive any intervention. All participants were offered 10 acupuncture sessions to be used between weeks 24 and 52. Main Outcomes and Measures
The primary end point was the 6-week BPI-WP score. Mean 6-week BPI-WP scores were compared by study group using linear regression, adjusted for baseline pain and stratification factors (clinically meaningful difference specified as 2 points). Results
Among 226 randomized patients (mean [SD] age, 60.7 [8.6] years; 88% white; mean [SD] baseline BPI-WP score, 6.6 [1.5]), 206 (91.1%) completed the trial. From baseline to 6 weeks, the mean observed BPI-WP score decreased by 2.05 points (reduced pain) in the true acupuncture group, by 1.07 points in the sham acupuncture group, and by 0.99 points in the waitlist control group. The adjusted difference for true acupuncture vs sham acupuncture was 0.92 points (95% CI, 0.20-1.65;P = .01) and for true acupuncture vs waitlist control was 0.96 points (95% CI, 0.24-1.67;P = .01). Patients in the true acupuncture group experienced more grade 1 bruising compared with patients in the sham acupuncture group (47% vs 25%;P = .01). Conclusions and Relevance
Among postmenopausal women with early-stage breast cancer and aromatase inhibitor–related arthralgias, true acupuncture compared with sham acupuncture or with waitlist control resulted in a statistically significant reduction in joint pain at 6 weeks, although the observed improvement was of uncertain clinical importance. Trial Registration
ClinicalTrials.gov Identifier:NCT01535066
科研通智能强力驱动
Strongly Powered by AbleSci AI